MC
VMD icon

Martin & Co’s Viemed Healthcare VMD Stock Holding History

Martin & Co’s Portfolio VMD Stock Details VMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.88M Buy
340,771
+67,770
+25% +$671K 0.61% 50
2026
Q1 		$2.51M Buy
+273,001
New +$2.27M 0.43% 69

Other funds holding VMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Forager Capital Management Birmingham, Alabama $266M AUM 40% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return

Martin & Co's VMD Position: Q2 2026 in Review

Martin & Co increased its Viemed Healthcare (VMD) stake by 25% in Q2 2026, buying an estimated $671K and bringing the position to 340,771 shares worth $3.88M. The position accounts for 0.61% of the portfolio, ranked #50.

Martin & Co first reported a position in VMD in Q1 2026 and has held it in 2 quarters since. 167 funds tracked by Wall St. Rank hold VMD as of Q2 2026.

  • Martin & Co held 340,771 shares of Viemed Healthcare worth $3.88M as of Q2 2026.
  • Martin & Co bought 67,770 Viemed Healthcare shares in Q2 2026, an estimated $671K.
  • Viemed Healthcare made up 0.61% of Martin & Co's portfolio in Q2 2026, its #50 holding.
  • Martin & Co first reported a position in Viemed Healthcare in Q1 2026 and has held it in 2 quarters since.
  • 167 funds tracked by Wall St. Rank held Viemed Healthcare as of Q2 2026.

Based on Martin & Co's 13F filing for Q2 2026, filed 12 Aug 2026.